VANCOUVER, April 18 /PRNewswire-FirstCall/ - Angiotech Pharmaceuticals, Inc. , a global specialty pharmaceutical and medical device company, will host a conference call discussing its financial results for the first quarter ended March 31, 2007.
Wednesday, May 2, 2007 at 11:00 AM (ET) (8:00 AM Pacific, 9:00 AM Mountain, 10:00 AM Central) Dial information is as follows: North America (toll-free): (866) 356-3377 International: (617) 597-5392 Enter passcode: 11344276
A live webcast will be available to all interested parties through Angiotech's website at www.angiotech.com under the Investors Relations section.
A press release announcing Angiotech's financial results will be issued prior to the conference call at approximately 10:00 AM ET (7:00 AM Pacific, 8:00 AM Mountain, 9:00 AM Central).
A replay archive of the conference call will be available until May 9, 2007. Replay archive information is as follows: North America: (888) 286-8010 International: (617) 801-6888 Enter passcode: 22452592 About Angiotech Pharmaceuticals
Angiotech Pharmaceuticals, Inc. is a global specialty pharmaceutical and medical device company with 17 facilities in 6 countries and over 1,500 dedicated employees. Angiotech discovers, develops and markets innovative treatment solutions for diseases or complications associated with medical device implants, surgical interventions and acute injury. To find out more about Angiotech , please visit our website at www.angiotech.com.
CONTACT: Analysts, Institutional, and Retail Investors: Deirdre Neary, Manager, Investor Relations, Angiotech Pharmaceuticals, Inc., (604) 222-7056, dneary@angio.com; Media: Jodi Regts, Manager, Corporate Communications, Angiotech Pharmaceuticals, Inc., (604) 221-7930, jregts@angio.com
Angiotech Pharmaceuticals, Inc.CONTACT: Analysts, Institutional, and Retail Investors: Deirdre Neary,Manager, Investor Relations, Angiotech Pharmaceuticals, Inc., (604)222-7056, dneary@angio.com; Media: Jodi Regts, Manager, CorporateCommunications, Angiotech Pharmaceuticals, Inc., (604) 221-7930,jregts@angio.com
